Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Condition: Advanced Lung Carcinoma
NCT04924192
A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.